A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

International Clinical Psychopharmacology

Volumn 16, Issue 3, 2001, Pages 169-178

  Montgomery, S A ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Anxiety; Clomipramine; Major depression; Meta analysis; Paroxetine; Tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DOXEPIN; IMIPRAMINE; MAPROTILINE; MIANSERIN; NORTRIPTYLINE; PAROXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME;

EID: 0035035006     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200105000-00006     Document Type: Article

References (50)

1. SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability
2. The efficacy of selective serotonin reuptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants
3. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: A meta-analysis
4. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients
5. A double-blind multi-centre study of paroxetine and amitriptyline in depressed outpatients
6. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice
7. Paroxetine: A selective serotonin uptake inhibitor showing better tolerance, but weaker antidepressant effect, than clomipramine in a controlled multi-center study
8. The role of serotonin in panic, anxiety and depression
9. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline
10. The treatment of depression: Prescribing patterns of antidepressants in primary care in the UK
11. Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom 1993-5
12. Sleep and paroxetine: A comparison with mianserin in elderly depressed patients
13. The anti-anxiety and anti-agitation effects of paroxetine in depressed patients
14. Two combined, multi-center double-blind studies of paroxetine and doxepin in geriatric patients with major depression
15. A study comparing paroxetine, placebo and imipramine in depressed patients
16. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients
17. Clinical characteristics of patients with concurrent major depressive disorder and panic disorder
18. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders
19. A rating scale for depression
20. Discontinuation rates of SSRIs and tricyclic antidepressants: A meta-analysis and investigation of heterogeneity
21. A double-blind comparison of paroxetine and amitriptyline in elderly depressed community patients
22. A double-blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients
23. Pharmacological characterization of selective serotonin reuptake inhibitors
24. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment
25. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
26. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey
27. Suicide attempt history in depressed patients with and without a history of panic attacks
28. A multi-centre double-blind comparative study between paroxetine and maprotiline in major depression
29. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder
30. Panic and depression: A worldwide primary care perspective
31. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder
32. Depression in the community: The first pan-European study DEPRES (Depression Research in European Society)
33. General practitioners' perceptions of the tolerability of antidepressant drugs: A comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants
34. Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates
35. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo
36. Antidepressants in panic disorder: Clinical and preclinical mechanisms
37. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice
38. Outcome of depression and anxiety in primary care. A three-wave 3.5-year study of psychopathology and disability
39. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care
40. Recognition and management of depression in general practice: Consensus statement
41. A multi-centre, double-blind study to compare the efficacy and tolerability of paroxefine and clomipramine in elderly patients with reactive depression
42. A double-blind, multi-center study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety
43. Paroxetine in the treatment of severe depression
44. A double-blind, multi-centre study of paroxetine and maprotiline in major depression
45. Course of depression in patients with comorbid anxiety disorders
46. Prevalence of comorbid anxiety disorders in primary care outpatients
47. Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability
48. Mixed depression and anxiety: Serotonin1 A receptors as a common pharmacologic link
49. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind, randomized trial in major depression